Objective-Interleukin-1 (IL-1) is a major cytokine linking inflammation and angiogenesis in pathological vascular processes, such as atherosclerosis and tumor neoangiogenesis. However, signaling pathways mediating IL-1-induced proangiogenic processes in endothelial cells (ECs) have barely been elucidated yet. Therefore, the present study investigated IL-1-induced proangiogenic signaling in ECs. Methods and Results-IL-1 potently induced tube formation and migration of ECs. This was associated with and dependent on activation of p38-mitogen-activated protein kinase (MAPK) and MAPK-activated protein kinase 2 (MK2) as determined by pharmacological inhibition and gene silencing. Furthermore, silencing of the adaptor protein tumor necrosis factor receptor-associated factor 6 (TRAF6) (lentiviral short hairpin RNA) inhibited these IL-1-induced processes. Moreover, IL-1 promoted translocation of TRAF6 to insoluble cellular fractions (containing membrane rafts/caveolae) and interaction of TRAF6 with caveolin-1. Accordingly, cellular cholesterol depletion (cyclodextrin) and silencing of caveolin-1 (small interfering RNA) inhibited IL-1-induced activation of p38-MAPK and MK2, as well as IL-1-induced tube formation and migration. Finally, silencing of TRAF6 and MK2 deficiency inhibited IL-1-induced microvessel outgrowth in murine aortic rings ex vivo, and deficiency of MK2 or caveolin-1 significantly reduced IL-1induced angiogenesis in mice in vivo (Matrigel plug assay). Conclusion-IL-1 assembles a proangiogenic signaling module consisting of caveolin-1, TRAF6, p38-MAPK, and MK2
I nterleukin-1 (IL-1) is a major cytokine playing a prominent role in the development of proinflammatory processes. Recent evidence has pointed to IL-1 as a pivotal molecule linking inflammation and angiogenesis in vascular pathophysiological processes such as atherosclerosis and tumor neoangiogenesis. 1 IL-1 is known to regulate expression of proangiogenic factors in tumor cells, contributing to angiogenesis and tumor growth. 2 Importantly, IL-1-deficient mice exhibit dramatically impaired tumor development and blood vessel growth, 3 and administration of IL-1-receptor antagonists inhibits tumor growth and neovascularization. 4 In addition, previous studies have demonstrated that monocyte-and macrophage-derived IL-1 induces angiogenesis in the chick embryo chorioallantoic membrane assay and Matrigel plaque assay, respectively. 5, 6 However, IL-1-mediated proangiogenic processes and the underlying signaling pathways in endothelial cells (ECs) have barely been elucidated yet.
IL-1 elicits its proinflammatory effects via activation of nuclear factor (NF)-B and mitogen-activated protein kinase (MAPK) signaling pathways. 7, 8 In this regard, the adaptor molecule tumor necrosis factor receptor-associated factor 6 (TRAF6) is essential for mediating and modulating IL-1dependent downstream signaling. Moreover, TRAF6 has been shown to mediate proangiogenic processes on lipopolysaccharide stimulation, which was associated with the activation of NF-B and c-Jun N-terminal kinase. 9 In addition, p38-MAPK and its downstream target MAPK-activated protein kinase 2 (MK2) may also exhibit an important role in angiogenesis, as they represent key regulatory molecules for cell sprouting, migration, proliferation, and actin polymerization in different cell types. 10, 11 However, the functional role of p38-MAPK and MK2 in IL-1-induced proangiogenic processes and signaling in ECs remains to be clarified. Recently, the function of members of the TRAF protein family has been linked to cholesterol-enriched domains in the plasma membrane called lipid rafts/caveolae. 12, 13 In ECs, these membrane regions are called caveolae, and the inner surface of these regions is coated with the scaffolding protein caveolin-1. The latter has been shown to play a major role in the regulation of vesicular trafficking and signal transduction in ECs. [14] [15] [16] In addition, several studies indicate that caveolin-1 plays a critical role in the regulation of vascular homeostasis and angiogenesis. [14] [15] [16] However, a functional link between TRAF6 and caveolin-1 has not been shown yet. Based on these facts, the present study investigated the potential of IL-1 to induce proangiogenic processes in ECs and elucidated the underlying signaling pathways.
Methods
A detailed description of the experimental procedures used in this study is provided in the online-only Data Supplement.
Cell Culture and small interfering rNa transfection
Human umbilical vein endothelial cells (HUVECs) were cultured in endothelial growth medium as recommended by the provider (Promocell). Small interfering RNA (siRNA) transfection was performed with siRNA (10 nmol/L, control-siRNA, MK2-siRNA, caveolin-1-siRNA) and transfection compound (Hiperfect) as recommended by the manufacturer (Qiagen). Transfection efficiency (98%) was determined by transfecting Alexa 588-labeled siRNA, and effective silencing was demonstrated by Western blotting for each experiment.
scratched Wound assay
Defined wound areas were created by scraping confluent HUVEC monolayers with a sterile disposable rubber policeman. The wound area was measured before and 24 hours after treatment as indicated using ImageJ (National Institutes of Health).
Matrigel angiogenesis assay in Vitro
HUVECs were plated onto growth factor-reduced Matrigel (BD Biosciences) and stimulated as indicated. Tube-like structures were analyzed by phase-contrast photomicrographs.
aortic ring sprouting assay
Sprouting of cells was analyzed in aortic rings from wild-type mice (C57BL/6J, Charles River Laboratories) or MK2-deficient mice 17 embedded and cultured in growth factor-depleted Matrigel and cultured as indicated. Microvessel outgrowth was visualized by phase-contrast imaging (Olympus 1X2-UCB microscope, magnification 310).
Matrigel Plug angiogenesis assay in Vivo
Ten-to 12-week-old wild-type mice, caveolin-1-deficient mice (Jackson Laboratory), and MK2-deficient mice 17 (all C57BL/6J) received injections of sterile chilled growth factor-reduced Matrigel supplemented with IL-1 (10 ng/mL), vascular endothelial growth factor (50 ng/mL), or control solvent ( phosphate-buffered saline). Six days after implantation, Matrigel plugs were analyzed for hemoglobin content and von Willebrand factor-positive vessels as indicated.
results

iL-1b induces tube Formation and Migration of eCs via p38-MaPK and MK2
To investigate the functional role of IL-1 for proangiogenic processes in ECs, we performed Matrigel tube formation and wound scratch assays using HUVECs. IL-1 potently induced tube formation in the Matrigel assay ( Figure 1A and 1B) and migration of ECs in the wound scratch assay ( Figure IA and IB in the online-only Data Supplement). In addition, IL-1 strongly induced activation of p38-MAPK and its downstream target MK2 in ECs ( Figure 2B ). As p38-MAPK and MK2 represent key regulatory molecules for processes known to be important in angiogenesis, such as cell sprouting, migration, proliferation, and actin polymerization, 10, 11 we determined the functional role of p38-MAPK and MK2 for IL-1-induced tube formation and cell migration in ECs. Pharmacological inhibition of p38-MAPK (SB203580, 10 mol/L) inhibited IL-1-induced tube formation ( Figure 1A 
silencing of traF6 in eCs inhibits iL-1b-induced activation of p38-MaPK and MK2, as Well as tube Formation and Migration of eCs
The adaptor molecule TRAF6 represents an important signaling molecule mediating IL-1-dependent signaling to its downstream effectors. 7, 8 To explore a functional role of TRAF6 for the IL-1-induced activation of p38-MAPK and MK2 in ECs, we investigated the IL-1-induced activation of p38-MAPK and MK2 in ECs by silencing TRAF6 expression using lentiviral-overexpressed TRAF6-short hairpin RNA (shRNA). Overexpression of TRAF6-shRNA potently reduced protein expression of TRAF6 in ECs ( Figure 2A ) and markedly reduced the IL-1-induced activation of p38-MAPK, MK2 and its downstream target heat shock protein 27 (Hsp27) ( Figure 2B ), the latter of which is known to modulate cytoskeletal organization and thereby cell migration. 18 In addition, silencing of TRAF6 expression in ECs abolished the IL-1-induced tube formation ( Figure 2C and 2D) and cell migration ( Figure IIA and IIB in the online-only Data Supplement). These findings indicate that TRAF6 mediates IL-1-induced activation of p38-MAPK, MK2, and Hsp27, as well as proangiogenic processes, such as tube formation and migration in ECs.
depletion of Cellular Cholesterol and silencing of Caveolin-1 inhibits iL-1b-induced translocation of traF6 into insoluble Cellular Fractions and traF6-Caveolin-1 interaction in eCs
As there is growing evidence for a functional role of caveolae/ caveolin-1 in intracellular signaling and proangiogenic processes, we investigated a potential role of caveolae/ caveolin-1 in IL-1-induced and TRAF6-mediated proangiogenic processes and signaling in ECs. First, we investigated whether TRAF6 translocates IL-1 dependently to insoluble cellular fractions (containing cellular membranes and membrane rafts/caveolae) and interacts with caveolin-1. At baseline, the majority of TRAF6 was localized in the soluble fraction, and caveolin-1 was exclusively localized in the insoluble cellular fraction ( Figure 3A and 3B). Stimulation of ECs with IL-1 caused a marked accumulation of TRAF6 in the insoluble cellular fraction and a time-dependent interaction with caveolin-1, as determined by coimmunoprecipitation ( Figure 3A-3C ). To evaluate a potential significance of caveolae/caveolin-1 for IL-1-induced TRAF6 translocation into the insoluble cellular fraction, we next assessed the effect of depletion of cellular cholesterol by cyclodextrin (also known to disrupt caveolae), 19 as well as of silencing of caveolin-1 (siRNA) on TRAF6 translocation. Importantly, the IL-1-induced enrichment of TRAF6 into the insoluble cellular fraction was prevented by cyclodextrin pretreatment in ECs ( Figure 3A) . Similarly, silencing of caveolin-1 (siRNA) prevented the IL-1-induced translocation of TRAF6 to the insoluble cellular fraction in ECs ( Figure 3B ). These results indicate that functional disruption of caveolae by cholesterol sequestering or inhibition of caveolin-1 expression blocked the IL-1-dependent TRAF6 translocation into insoluble cellular fractions, containing cellular membranes, membrane rafts, and caveolae, pointing to a functional role of caveolae/caveolin-1 as a signaling platform for TRAF6-dependent IL-1 signaling in ECs.
depletion of Cellular Cholesterol and silencing of Caveolin-1 inhibits iL-1b-induced activation of p38-MaPK and MK2, tube Formation, and Migration of eCs
Based on these data, a potential role of caveolin-1/caveolae for IL-1-induced activation of p38-MAPK and MK2, as well as proangiogenic processes (tube formation, migration), in ECs was investigated by depletion of cellular cholesterol (cyclodextrin, filipin), as well as silencing of caveolin-1 (siRNA). Pretreatment of ECs with cyclodextrin or filipin, as well as silencing of caveolin-1 expression (siRNA), markedly reduced the IL-1-induced activation of p38-MAPK, MK2, and Hsp27 ( Figure 3D (Figures 2A, 3B , and 3E) might be responsible for the reduced but not abolished activation of p38-MAPK, MK2, and Hsp27. Similarly, complete disruption of caveolae by cyclodextrin and filipin seemed to be unlikely in our experiments. 20 Therefore, formation of signaling complexes targeted by IL1- in the remaining (but diminished in number) caveolae might explain the markedly reduced but persistent activation of p38-MAPK, MK2, and Hsp27. However, the markedly impaired activation of p38-MAPK, MK2, and Hsp27, although not abrogated, might fall below a certain threshold required to modulate intracellular signaling processes favoring tube formation and migration. This might explain the observed inhibition of tube formation and migration despite the remaining low-level activation of p38-MAPK, MK2, and Hsp27.
To exclude IL-1 receptor reduction/removal from the cell surface by depletion of cholesterol and caveolin-1 and therefore its availability for IL-1-dependent ligation subsequently affecting IL1 receptor-dependent signaling, we performed fluorescence-activated cell sorting analysis to determine the cell surface expression of IL-1 receptor I. Neither cholesterol depletion by cyclodextrin nor depletion of caveolin-1 by siRNA affected cell surface expression of IL-1 receptor I ( Figure IV in the online-only Data Supplement).
Furthermore, as we observed a lower IL-1-induced angiogenesis after treatment with the p38-MAPK inhibitor, MK2-siRNA, and cyclodextrin than in IL-1-untreated 
iL-1b-induced Microvessel sprouting and angiogenesis is dependent on traF6, Caveolin-1, and MK2
To evaluate the functional role of TRAF6 and its downstream effector MK2 on IL-1-induced proangiogenic processes in the intact vascular context, we performed an ex vivo microvessel sprouting assay using murine aortic rings. As TRAF6-deficient mice die soon after birth, 21, 22 aortic rings obtained from wild-type mice transduced with lentiviral TRAF6-shRNA to knock down TRAF6 expression were used. TRAF6-shRNA almost completely abolished the IL-1-induced microvessel outgrowth observed in aortic rings transduced with lentiviral control shRNA ( Figure VIA and VIB in the online-only Data Supplement). In addition, we investigated whether the IL-1-TRAF6-dependent downstream effector MK2 mediates microvessel sprouting using aortas isolated from MK2-deficient mice. MK2 deficiency in aortic rings almost completely abolished the IL-1-dependent microvessel sprouting as compared with aortas isolated from wild-type mice ( Figure VIC and VID in the online-only Data Supplement). The observed impact of TRAF6-silencing and MK2 deficiency on IL-1-induced microvessel sprouting in the aortic ring assay ex vivo supports our in vitro results demonstrating that IL-1 potently induces proangiogenic processes via TRAF6, p38-MAPK, and MK2 in ECs. Finally, we proved the functional role of the IL-1/caveolin-1/MK2 signaling axis in vivo using the Matrigel plug assay in wild-type, caveolin-1-deficient, and MK2-deficient mice. In line with our data obtained in vitro and ex vivo, deficiency of caveolin-1, as well as deficiency of MK2, significantly reduced IL-1induced angiogenesis in implanted Matrigel plugs in vivo ( Figure 5A-5D ). Representative blots of at least 3 independent experiments are shown. C, HUVECs were stimulated with IL-1 (1 ng/mL) for the indicated times, and immunoprecipitation of caveolin-1 from cell lysates followed by Western blotting against TRAF6 was performed. D and E, HUVECs were pretreated with cyclodextrin (10 mmol/L, 30 minutes) or filipin (5 g/mL, 30 minutes) or not pretreated (D), as well as with caveolin-1 siRNA or control siRNA (E), and stimulated with IL-1 (1 ng/mL, 30 minutes). Expression of phospho-p38 (pp38), phospho-MK2 (pMK2), and phospho-Hsp27 (pHSP27) was determined in whole cell lysates by Western blotting. Expression of p38, MK2, and Hsp27 served as loading control. Representative blots of at least 3 separate experiments are shown. A B D E C discussion Angiogenesis, the formation of new blood vessels from preexisting ones, is a complex process involving breakdown of the extracellular matrix, sprouting, migration, and proliferation of ECs, and recruitment of pericytes. 23 Angiogenesis plays a paramount role in tumor growth and wound healing. Moreover, a relationship between inflammation and angiogenesis is now widely accepted in different diseases, such as atherosclerosis. 2, 24 Because of their strategic position in the lining of blood vessels, ECs can be a target for circulating or locally produced cytokines, such as IL-1. Although the proinflammatory cytokine IL-1 was reported to increase tumor invasiveness and metastasis and the administration of IL-1-receptor antagonist inhibits tumor growth and neovascularization, 2-4 there is not much evidence regarding the molecular mechanism of IL-1-dependent proangiogenic processes in ECs. In our experiments, IL-1 very potently induced proangiogenic processes, such as tube formation and migration of ECs in vitro, in the aortic ring sprouting assay ex vivo, as well as in the Matrigel plug assay in vivo. Indicating a potential important role of p38-MAPK and MK2 for proangiogenic processes, p38-MAPK and MK2 were also recognized to represent key regulatory molecules for cell sprouting, migration, and proliferation and actin polymerization in different cell types. 10, 11 Consistently, in the present study, we demonstrated that IL-1-induced migration, as well as tube formation, is mediated via activation of p38-MAPK and MK2 in ECs. Furthermore, our results provide evidence that the adaptor protein TRAF6 mediates IL-1-dependent tube formation and migration via p38-MAPK and MK2 in ECs. In this context, TRAF6-dependent activation of p38-MAPK is most likely mediated via the transforming growth factor (TGF)--activated kinase 1 (TAK1)/TAK1-binding protein 1 (TAB1)/TAB2 signaling complex. After IL-1 receptor ligation, phosphorylated IRAK-1 and TRAF6 dissociate from the receptor and interact with a preformed complex consisting of TAK1, TAB1, and TAB2. This interaction induces phosphorylation of TAB2 and TAK1. In the cytosol, the multimeric protein complex composed of TRAF6, TAK1, TAB1, and TAB2 leads to ubiquitination of TRAF6, triggering TAK1 kinase activity. Then, activated TAK1 phosphorylates and activates the MAPK kinases (MKKs) MKK3 and 6, which subsequently phosphorylate and activate p38-MAPK. 8 Supporting our data demonstrating IL-1induced angiogenesis mediated via TRAF6, a recent report also showed the importance of TRAF6 in lipopolysaccharide-mediated angiogenesis in human dermal microvascular ECs. 9 Finally, our in vitro data were confirmed by the aortic ring microvessel sprouting assay ex vivo and the Matrigel plug assay in vivo, showing the robust angiogenic capacity of IL-1 mediated via TRAF6 and the major downstream target of p38-MAPK MK2.
However, previous studies have shown that treatment of ECs with IL-1 either has no effects or inhibits angiogenesis/ angiogenic processes (Matrigel plug/aortic ring assay). 6, 25 However, the reported inhibitory effect of IL-1 on angiogenesis was observed with rat cardiac microvascular ECs and therefore is most likely due to the different species and origin of cells used compared with the present study. Carmi et al 6 investigated cell culture supernatants for their angiogenic capacity isolated from lipopolysaccharide-treated macrophages or cultured cells isolated after infiltration of Matrigel plaques implanted in mice. They nicely demonstrated IL-1dependent angiogenesis in these models. However, by their experimental setup, they could not clearly dissect a direct or primarily indirect (eg, via vascular endothelial growth factor induction) action of IL-1 on EC-dependent angiogenesis. As also claimed by these authors, cytokine concentrations in the supernatants used in their studies might have not been sufficient to induce angiogenic processes (eg, aortic ring sprouting). Especially taking in consideration that IL-1, released during intercellular interactions, might locally exceed the concentrations (as used in the present study) directly activating IL-1-receptor dependent intracellular signaling, the above-mentioned reports do not exclude the direct IL-1induced proangiogenic processes in ECs suggested by the present study.
Recent data have linked membrane lipid rafts/caveolae with signaling molecules and pathways in ECs. Caveolin-1, a highly abundant protein of caveolae in ECs, might regulate cellular responses such as Ca 21 entry and activation of endothelial nitric oxide synthase by modulating protein-protein interactions. Therefore, caveolin-1 serves as a structural core for the interaction of plasma membrane-associated proteins, including G-proteins, Src kinases, epidermal growth factor receptors, MAPKs, and endothelial nitric oxide synthase. 15, 16 In this regard, recent observations suggest that translocation of TRAF proteins to lipid rafts represents a key element in cytokine-dependent signaling. On CD40 stimulation TRAF2, TRAF3, and TRAF6 were shown to be recruited to lipid rafts by putative zinc finger domains in B cells and HEK cells. 26, 27 In addition, previous studies also presented a crucial role of TRAF6 association with lipid rafts for receptor activator of NF-B (RANK) signaling. Disruption of lipid rafts blocked RANK-dependent TRAF6 translocation and activation of AKT signaling in osteoclasts. 28, 29 Furthermore, recruitment of tumor necrosis factor (TNF) receptor 1 and TRAF2 to lipid rafts was shown to be crucial for TNFa-induced NF-B activation and apoptosis, as well as for activation of phosphatidylinositol 3-kinase/AKT signaling in 
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ECs. 30, 31 Moreover, Toll-like receptor 2-activated signaling was shown to be enriched in caveolin-1-associated lipid raft microdomains, forming a signaling complex including myeloid differentiation protein 88, IL-1 receptor kinase-1, and TRAF6 in airway epithelial cells. 32 Previous studies also addressed the functional role of caveolin-1 in ECs for angiogenesis. In these studies, overexpression of caveolin-1 in ECs enhanced generation of capillary tube formation, and silencing of caveolin-1 by an antisense adenoviral approach reduced capillary-like tube formation in Matrigel assays. 33 Furthermore, Matrigel plug assays and injection of B16 melanoma cells into caveolin-1 knockout mice revealed a dramatic reduced blood vessel infiltration and density, as well as disorganized capillary formation, compared with wild-type mice. 34 Accordingly, our data showed that TRAF6 and caveolin-1 colocalize in the same insoluble cellular fraction (containing membrane rafts/caveolae) and interact after IL-1 stimulation in ECs. Consistently with these data, depletion of cellular cholesterol with cyclodextrin (also known to disrupt caveolae besides affecting other targets), as well as silencing of caveolin-1, blocked the IL-1-induced translocation of TRAF6 into the insoluble cellular fraction.
Our immunoprecipitation experiments showed an IL-1dependent association of TRAF6 with caveolin-1 in ECs. These data indicate a direct modulation of TRAF6-dependent signaling by caveolin-1. To our knowledge, this has not been described before. Interestingly, a TNF-dependent interaction of TRAF2 with caveolin-1 has also been reported in HUVECs. 12 Similar to the inhibitory effect of caveolin-1 silencing on IL-1-dependent signaling observed in the present study, D'Alessio et al also described an inhibition of TNF-induced activation of c-Jun N-terminal kinase but also p38-MAPK after silencing of caveolin-1 in ECs. 35 In contrast, TNF-induced degradation of I-Ba, indicating activated NF-B signaling, was not affected. Moreover, silencing of caveolin-1 has been described to inhibit TNF-induced cyclooxygenase-2 expression in pulmonary porcine ECs. 36 Hence, promoting or inhibitory modulation of inflammatory signaling by caveolin-1 seems to be specifically dependent on the cell type, signaling pathway, and target protein. This differs from the well-described classical function of caveolin-1 as a negative regulator of the endothelial NO synthase in ECs. [14] [15] [16] However, the exact molecular mechanisms of caveolin-1 dependent regulation of inflammatory signaling modules such as NF-B and MAPK and especially the potential interaction of caveolin-1 with signaling molecules such as TRAFs still have to be elucidated in further studies. However, in our studies, depletion of cellular cholesterol (known to inhibit formation of membrane rafts/ caveolae) and silencing of caveolin-1 in ECs inhibited the IL-1-induced activation of p38-MAPK and MK2, as well as the IL-1-induced tube formation and migration. These data suggest that caveolae and caveolin-1 are necessary for IL-1-induced proangiogenic processes in ECs mediated via TRAF6, p38-MAPK, and MK2.
Of course, depletion of cholesterol and caveolin-1 may also affect the recruitment of various adaptor proteins known to form a signaling complex after ligation of the IL-1-receptor, such as myeloid differentiation protein 88, IL-1 receptor kinases, TRAF6, TAB1/TAB2, and TAK-1, thereby impairing IL-1-dependent downstream signaling. 8, 37 Therefore, the present work should stimulate further research to dissect in more detail the molecular mechanisms by which caveolae and caveolin-1 modulate signaling complex formation and thereby modulate downstream signaling after ligation of the IL-1-receptor.
In summary, our experiments provide evidence that IL-1 assembles a signaling module consisting of caveolae/ caveolin-1, TRAF6, p38-MAPK, and MK2 inducing proangiogenic processes in ECs ( Figure 6 ). This IL-1-dependent proangiogenic signaling module might represent an attractive target to intervene into angiogenesis-dependent processes and diseases.
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